ITEMS IN AFP WITH KEYWORD:
Aug 15, 2017 Issue
Screening for Gynecologic Conditions with Pelvic Examination [Putting Prevention into Practice]
A 37-year-old woman presents to your office for her annual wellness visit. She is not due for a Papanicolaou (Pap) smear this year. She is not pregnant, reports no problems, and has no risk factors for sexually transmitted infections. She asks if she should have a pelvic examination today.
Patients may be hesitant to discuss pelvic floor disorders such as prolapse with their physicians. A high number of women are affected by prolapse, and the causes and risk factors are broad.
Jul 1, 2017 Issue
Surgery vs. Medical Therapy for Heavy Menstrual Bleeding [Cochrane for Clinicians]
In women of reproductive age with chronic heavy menstrual bleeding, hysterectomy is the most effective treatment for controlling symptoms. Conservative surgery is more effective for controlling bleeding symptoms at one and two years than oral medications or the levonorgestrel-releasing intrauterine system, but by five years there is no difference.
In women with mild to moderate pelvic floor prolapse, a formal program including physiotherapist-guided pelvic floor exercises only modestly improved symptoms.
In rural communities, physicians and their patients are uniquely bonded. These relationships can be a source of encouragement and healing.
Find out which patients can be followed with watchful waiting, when to choose medical therapy over surgery, and which drugs and procedures have the best evidence.
Compared with placebo, thiazolidinediones (TZDs) decrease systolic blood pressure and fasting blood glucose and insulin levels while improving menstrual irregularities in women with PCOS. Metformin and TZDs have similar effects on pregnancy rates, ovulation, and menstrual frequency, but TZDs can cau...
Polycystic ovary syndrome is a common and complex endocrinopathy. Evidence for the pathology involves identifying at least two of three key criteria. Treatment should be guided by patient preference and presentation of the disease, because some therapies may conflict with a woman’s desire to have children.
The levonorgestrel-releasing intrauterine system achieves significantly higher resolution rates of endometrial hyperplasia without atypia compared with cyclic oral progestins (68% to 100% vs. 48% to 69%, respectively).
Find out which tests should be ordered initially, what red flag signs to look for, which pharmacologic and nonpharmacologic treatments are supported by the evidence, and when to refer patients for laparoscopy or long-term opioid therapy.